This week, metabolic fitness platform Ultrahuman announced its acquisition of wearables company LazyCo, best known for its Aina ring product. This marks the first step by the Bangalore-based company to expand the metabolic health biomarkers covered in its current wearable, the futuristic-sounding Ultrahuman M1.

Longevity.Technology: Integrating biology with technology, wearables and the AI that powers them are allowing more and more people to take autonomy over their own health. From the ubiquitous Fitbit to more advanced tech, it is common to see wearables on wrists everywhere you go. They aren’t just for show though, as they allow their wearers to continuously monitor their health by measuring biomarkers from heart rate to bioelectric signals. The industry is growing exponentially and is expected to reach $37.67 billion by 2025.

Ultrahuman’s focus on metabolic health is highly relevant to longevity. Metabolic health disorders contribute to almost 85% of all chronic diseases globally. Over one billion people suffer from metabolic disorders – defined as conditions that affect any part of the metabolism and include diabetes. Fortunately, metabolic conditions can be largely influenced by lifestyle factors like diet and exercise. By tracking your biometric data, wearable devices can help you understand how your daily choices affect metabolic health.

Ultrahuman was founded by sports and biohacking enthusiasts Mohit Kumar and Vatsal Singhal. While training at a mixed martial arts camp in Thailand, Kumar observed athletes using data, recovery tools and protocols to optimise performance. Together with Singhal, they envisioned a platform for making people’s fitness journey more personalised and impactful.

Ultrahuman was launched as a metabolic health platform and wearable, the Ultrahuman M1, focusing primarily on tracking blood glucose biomarkers. The M1 monitors how different foods affect the wearer’s metabolism throughout the day by measuring the body’s glucose response, which depends on different factors like gut microbiome and stress levels. The data is then sent to its online platform that provides insights into exercise, sleep and nutrition to help improve the wearer’s metabolic score.

LazyCo meanwhile builds hardware products to make people’s lives easier, including the popular Aina ring. The AI-powered smart ring can automate everyday tasks, ranging from booking taxis to sending SOS alerts.

With the new acquisition, LazyCo is expected to enhance Ultrahuman’s wearable user experience, combining Ultrahuman’s AI and data expertise with LazyCo’s product design leadership to improve wearers’ metabolic health.

Aiming to replicate the success of the Aina ring, LazyCo founders Apoorv Shankar and Yogansh Namdeo will lead hardware product development at Ultrahuman.

“Ultrahuman’s vision of making health more personalized and impactful for people syncs with LazyCo’s vision of building products that solve problems for people in the most effortless ways,” said Shankar. “Together, we can create a deeper impact on the overall health of the world.”

The joint focus, said Ultrahuman’s Kumar, is on refining the user experience to make tracking your metabolic health as easy as possible.

“We want to make it easy to get healthy. At Ultrahuman, we’re deep believers in passive personalised health, specifically in a health platform that requires very minimal effort from a user’s perspective. This perfectly aligns with the philosophy of LazyCo.”

In their endeavour to improve metabolic health, Ultrahuman has raised $25 million in venture capital funding to date. This includes a $17.5 million Series B deal led by Alpha Wave Incubation (AWI), iSeed fund and Steadview Capital Management to refine its biomarker technology.